|
[1]
|
李茂军, 唐彬秩, 吴青, 等. 新生儿高胆红素血症的管理-美国儿科学会及多国临床管理指南解读[J]. 中华实用儿科临床杂志, 2023, 38(3): 161-168.
|
|
[2]
|
中华医学会儿科学分会新生儿学组, 《中华儿科杂志》编辑委员会. 新生儿高胆红素血症诊断和治疗专家共识[J]. 中华儿科杂志, 2014, 52(10): 745-748.
|
|
[3]
|
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia (2004) Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics, 114, 297-316. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
霍怡萱, 彭程, 侯新琳, 等. 美国儿科学会新生儿高胆红素血症临床指南修订: 胎龄35周及以上新生儿高胆红素血症的管理[J]. 中华新生儿科杂志(中英文), 2023, 38(9): 513-524.
|
|
[5]
|
李楠, 栗昊. 益生菌和维生素B2联合蓝光治疗新生儿高胆红素血症的效果及对患儿机体免疫功能的影响[J]. 当代医学, 2022, 28(5): 124-126.
|
|
[6]
|
王晓英, 顾益琴, 许丽娅. 地衣芽孢杆菌联合蓝光照射对新生儿高胆红素血症患儿黄疸消退时间及血清胆红素水平的影响[J]. 妇儿健康导刊, 2022, 1(7): 56-59.
|
|
[7]
|
Kemper, A.R., Newman, T.B., Slaughter, J.L., Maisels, M.J., Watchko, J.F., Downs, S.M., et al. (2022) Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics, 150, e2022058859. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
高璐, 芦起. 新生儿光疗不良反应研究进展[J]. 中华新生儿科杂志, 2021, 36(2): 75-78.
|
|
[9]
|
任念. 新生儿黄疸规范化用药指导专家建议[J]. 中国医药导报, 2019, 16(27): 105-110.
|
|
[10]
|
Dash, N., Kumar, P., Sundaram, V. and Attri, S.V. (2015) Pre-Exchange Albumin Administration in Neonates with Hyperbilirubinemia: A Randomized Controlled Trial. Indian Pediatrics, 52, 763-767. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Lieberman, L., Lopriore, E., Baker, J.M., Bercovitz, R.S., Christensen, R.D., Crighton, G., et al. (2022) International Guidelines Regarding the Role of IVIG in the Management of Rh-and Abo-Mediated Haemolytic Disease of the Newborn. British Journal of Haematology, 198, 183-195. [Google Scholar] [CrossRef] [PubMed]
|